-
Mashup Score: 6
ESMO 2021 IMvigor011 trial, radical cystectomy, cisplatin-based neoadjuvant chemotherapy, treatment options for MIBC, adjuvant atezolizumab versus placebo, VENTANA SP142 IHC assay.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
#IMvigor011: a global, double-blind, randomized phase 3 study of atezolizumab vs PBO as adjuvant therapy in pts with high-risk #MIBC who are ctDNA positive post cystectomy @tompowles1 @QMBCI. #ESMO21 coverage by @zklaassen_md @GACancerCenter > https://t.co/jDtjdP8al2 @myESMO https://t.co/Nf68uTL1XR